Brain scans reveal clues to mysterious MSA disorder
NCT ID NCT01136213
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the brain chemical serotonin works in people with multiple system atrophy (MSA), a rare and serious nerve disease. Researchers used special PET scans to measure serotonin receptors in the brains of 53 adults with MSA or Parkinson's disease. The goal was to learn more about what causes MSA symptoms, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Limoges
Limoges, France
-
CHU de Bordeaux
Bordeaux, 33076, France
-
CHU de Toulouse
Toulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a brain disease change behavior years before diagnosis?
- Can an experimental pill slow a rare brain disease? a trial puts ATH434 to the test.
- Can a new rowing seat help veterans with paralysis row freely?
- Scientists decode gait signatures to spot brain diseases
- Can a Thigh-Worn sensor outsmart dizziness questionnaires?
- Scientists hunt for clues to diagnose Parkinson's earlier